MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.03.2026
TELA Bio Kurzfristige Verbindlichkeiten 2011-2026 | TELA
Kurzfristige Verbindlichkeiten Jährlich TELA Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18 M | 15.6 M | 17 M | 12.4 M | 10.6 M | 6.6 M | 6.71 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18 M | 6.6 M | 12.4 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 12.24 | 1.7 % | $ 1.65 B |  USA |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.84 | 4.21 % | $ 158 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 10.96 | 1.2 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 33.3 | -3.31 % | $ 1.53 B | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.09 | -0.61 % | $ 866 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 36.54 | -0.58 % | $ 5.44 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 62.41 | -0.65 % | $ 92.4 B | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 9.32 | -0.48 % | $ 264 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 34.67 | -0.34 % | $ 1.08 B | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.6 | 2.73 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
27.6 M | $ 3.43 | 1.18 % | $ 128 M |  France |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 80.92 | -0.16 % | $ 47.3 B | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.59 | - | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 87.63 | -0.33 % | $ 11.8 B | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 170.68 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 1.87 | 0.54 % | $ 1.14 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.34 | -1.99 % | $ 719 M | USA |
 |
Inogen
INGN
|
63.5 M | $ 6.41 | 3.14 % | $ 171 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
10.2 M | $ 97.04 | 0.84 % | $ 1.23 B | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 85.1 | -2.01 % | $ 2.96 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 15.9 | -1.0 % | $ 373 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 6.01 | -0.91 % | $ 71.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.39 | 4.14 % | $ 56.6 M | USA |
 |
Medtronic PLC
MDT
|
12.9 B | $ 86.29 | -0.39 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.86 | -1.53 % | $ 570 M | USA |